Small-Molecule Ligands that Bind the RET Receptor Activate Neuroprotective Signals Independent of but Modulated by Coreceptor GFR alpha 1

Näytä kaikki kuvailutiedot



Pysyväisosoite

http://hdl.handle.net/10138/332075

Lähdeviite

Jmaeff , S , Sidorova , Y , Lippiatt , H , Barcelona , P F , Nedev , H , Saragovi , L M , Hancock , M A , Saarma , M & Saragovi , H U 2020 , ' Small-Molecule Ligands that Bind the RET Receptor Activate Neuroprotective Signals Independent of but Modulated by Coreceptor GFR alpha 1 ' , Molecular pharmacology : an international journal , vol. 98 , no. 1 , pp. 1-12 . https://doi.org/10.1124/mol.119.118950

Julkaisun nimi: Small-Molecule Ligands that Bind the RET Receptor Activate Neuroprotective Signals Independent of but Modulated by Coreceptor GFR alpha 1
Tekijä: Jmaeff, Sean; Sidorova, Yulia; Lippiatt, Hayley; Barcelona, Pablo F.; Nedev, Hinyu; Saragovi, Lucia M.; Hancock, Mark A.; Saarma, Mart; Saragovi, H. Uri
Tekijän organisaatio: Institute of Biotechnology
Päiväys: 2020-07-01
Kieli: eng
Sivumäärä: 12
Kuuluu julkaisusarjaan: Molecular pharmacology : an international journal
ISSN: 0026-895X
DOI-tunniste: https://doi.org/10.1124/mol.119.118950
URI: http://hdl.handle.net/10138/332075
Tiivistelmä: Glial cell line-derived neurotrophic factor (GDNF) binds the GFR alpha 1 receptor, and the GDNF-GFR alpha 1 complex binds to and activates the transmembrane RET tyrosine kinase to signal through intracellular Akt/Erk pathways. To dissect the GDNF-GFR alpha 1-RET signaling complex, agents that bind and activate RET directly and independently of GFR alpha 1 expression are valuable tools. In a focused naphthalenesulfonic acid library from the National Cancer Institute database, we identified small molecules that are genuine ligands binding to the RET extracellular domain. These ligands activate RET tyrosine kinase and afford trophic signals irrespective of GFR alpha 1 coexpression. However, RET activation by these ligands is constrained by GFR alpha 1, likely via an allosteric mechanism that can be overcome by increasing RET ligand concentration. In a mouse model of retinitis pigmentosa, monotherapy with a small-molecule RET agonist activates survival signals and reduces neuronal death significantly better than GDNF, suggesting therapeutic potential. SIGNIFICANCE STATEMENT A genuine ligand of RET receptor ectodomain was identified, which acts as an agonist. Binding and agonism are independent of a coreceptor glial cell line-derived neurotrophic factor family receptor a, which is required by the natural growth factor glial cell line-derived neurotrophic factor, and are selective for cells expressing RET. The lead agent protects neurons from death in vivo. This work validates RET receptor as a druggable therapeutic target and provides for potential leads to evaluate in neurodegenerative states. We also report problems that arise when screening chemical libraries.
Avainsanat: NEUROTROPHIC FACTOR GDNF
TYROSINE KINASE
RAT MODEL
FAMILY
TRKA
GROWTH
DEGENERATION
NEUROPATHY
MECHANISM
NEURTURIN
1182 Biochemistry, cell and molecular biology
Vertaisarvioitu: Kyllä
Pääsyrajoitteet: openAccess
Rinnakkaistallennettu versio: acceptedVersion


Tiedostot

Latausmäärä yhteensä: Ladataan...

Tiedosto(t) Koko Formaatti Näytä
mol.119.118950.full_1_.pdf 3.708MB PDF Avaa tiedosto

Viite kuuluu kokoelmiin:

Näytä kaikki kuvailutiedot